1Arico M, Nichols K, Whitlock JA, et al. Familial clustering of Langerhans cell histiocytosis[J]. Br J Haematol, 1999,107(4): 883-888.
2Pardanani A, Phyliky RL, Li CY, et al. 2-Chlorodeoxyadenosine therapy for disseminated Langerhans cell histiocytosis[ J]. Mayo Clin Proc,2003,78(3):301-306.
3Simonart T, Urbain F, Verdebout JM, et al. Langerhans' cell histiocytosis arising at the site of basal cell carcinoma excision[J]. J Cutan Pathol, 2000,27(9) :476-478.
4Dina A,Zahava V,Iness M. The role of vascular endothelial growth factor in Langerhans cell histiocytosis[ J]. J Pediatr Hematol Oncol, 2005,27 (2): 62-66.
5Culic S,Jakobson A, Culic V, et al. Etoposide as the basic and interferonalpha as the maintenance therapy for Langerhans cell histiocytosis: a RTC [J]. Pediatr Hematol Oncol,2001,18(4) :291-294.
6Bank MI, Rengtved P, Carstensen H, et al. Langerhans cell histiocytosis: an evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies[J] .APMIS,2003,111(2) :300-308.
7Leenen PJ, Egeler RM. Langerhans' cell histiocytosis is caused by dysregulation of the E-cadherin-beta-catenin cascade: a hypothesis [ J ].Immunol Cell Biol, 1999,77(5) :460-467.
8Aslan V, Akay OM, Durak B, et al. Langerhans cell histiocytosis with transformation to acute leukemia showing 45, X, t(8; 21 ), 5q-, -Y karyotype [ J]. Leuk Lymphoma, 2002,43 (8): 1683-1685.
9Robak T, Kordek R, Robak E, et al. Langerhans cell histiocytosis in a patient with systemic lupus erythematosus: a clonal disease responding to treatment with cladribine, and cyclophospharnide[ J]. Leuk Lymphoma, 2002,43 (10):2041-2046.
10Bouloc A, Boulland ML, Geissmann F, et al. CD101 expression by Langerhans cell histiocytosis cells [ J ]. Histopathology, 2000, 36 ( 3 ): 229-232.
